Print Page  |  Close Window


Please stop back for additional upcoming events. Thank you for your interest.

Corporate Profile

Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary modified-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have three approved ADHD products, two of which use our ODT technology and one of which is an extended-release (ER) oral suspension. Our growing ADHD product portfolio puts Neos in a unique position to help meet the different needs of patients that struggle with ADHD.

News Releases

» READ MORE Neos Therapeutics News

Corporate Whistleblower Hotline

Report online:

Call toll-free: (844) 375-8324 (24 hours a day, 7 days a week)

Anytime, from any location. You DO NOT have to give your name.